NorthStrive files patent application for muscle-wasting treatment EL-22

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. META
5. SPY
6. ACN
7. IBM
8. PRIM
9. PFE
10. TSLA

Go back to NorthStrive files patent application for muscle-wasting treatment EL-22
(NASDAQ: ELAB) Delayed: 1.30 -0.05 (3.7%)
Previous Close $1.35    52 Week High $ 
Open $1.30    52 Week Low $ 
Day High $1.35    P/E N/A 
Day Low $1.29    EPS $ 
Volume 231,467